Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion type Assertion NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_head.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion description "[Our results provide evidence for the feasibility and efficacy of the modification of HSPC with CAR as a strategy for generating multiple lineages of effector cells for immunotherapy against B-lineage malignancies to augment graft-versus-leukemia activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_provenance.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion evidence source_evidence_literature NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_provenance.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion SIO_000772 23978226 NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_provenance.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion wasDerivedFrom befree-20150227 NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_provenance.
- NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_assertion wasGeneratedBy ECO_0000203 NP838379.RAbfLqA_RjdZ7PQBQvEHnxDxC2Plj8OmcRRwRLd9ORRcw130_provenance.